T cell pathways involving CTLA4 contribute to a model of acute lung injury

Journal of Immunology

Volumn 184, Issue 10, 2010, Pages 5835-5841

  Nakajima, Takeshi ^a   Suarez, Carlos Jose ^a   Lin, Ko Wei ^a   Jen, Kai Yu ^a   Schnitzer, Jan E ^b   Makani, Samir S ^a   Parker, Nathan ^a   Perkins, David L ^a   Finn, Patricia W ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Proteogenomics Research Institute for Systems Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CD69 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY;

ACUTE LUNG INJURY; ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; HELPER CELL; LUNG LAVAGE; LYMPHOCYTE COUNT; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ANIMAL; B LYMPHOCYTE; BAGG ALBINO MOUSE; BIOSYNTHESIS; DISEASE MODEL; HOSPITALIZATION; IMMUNOLOGY; LYMPHOCYTOPENIA; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ACUTE LUNG INJURY; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; B-LYMPHOCYTE SUBSETS; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LYMPHOCYTE COUNT; LYMPHOPENIA; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS;

EID: 77954734870     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903238     Document Type: Article

References (35)

1. Ware, L. B., and M. A. Matthay. 2000. The acute respiratory distress syndrome. N. Engl. J. Med. 342: 1334-1349.
2. Rubenfeld, G. D., E. Caldwell, E. Peabody, J. Weaver, D. P. Martin, M. Neff, E. J. Stern, and L. D. Hudson. 2005. Incidence and outcomes of acute lung injury. N. Engl. J. Med. 353: 1685-1693.
3. Hirano, S. 1997. Quantitative time-course profiles of bronchoalveolar lavage cells following intratracheal instillation of lipopolysaccharide in mice. Ind. Health 35: 353-358. (Pubitemid 27338001)
4. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675-680.
5. Barton, G. M., and R. Medzhitov. 2002. Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14: 380-383.
6. Matsuguchi, T., K. Takagi, T. Musikacharoen, and Y. Yoshikai. 2000. Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes. Blood 95: 1378-1385. (Pubitemid 30099850)
7. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197: 403-411.
8. Marsland, B. J., C. Nembrini, K. Grün, R. Reissmann, M. Kurrer, C. Leipner, and M. Kopf. 2007. TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-theta signaling and promote autoimmune myocarditis. J. Immunol. 178: 3466-3473.
9. Mohammed, K. A., N. Nasreen, M. J. Ward, and V. B. Antony. 2000. Induction of acute pleural inflammation by Staphylococcus aureus. I. CD4+ T cells play a critical role in experimental empyema. J. Infect. Dis. 181: 1693-1699.
10. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, R. E. Schmieg, Jr., J. J. Hui, K. C. Chang, D. F. Osborne, B. D. Freeman, J. P. Cobb, T. G. Buchman, and I. E. Karl. 2001. Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J. Immunol. 166: 6952-6963.
11. Schwulst, S. J., J. T. Muenzer, K. C. Chang, T. S. Brahmbhatt, C. M. Coopersmith, and R. S. Hotchkiss. 2008. Lymphocyte phenotyping to distinguish septic from nonseptic critical illness. J. Am. Coll. Surg. 206: 335-342.
12. Hotchkiss, R. S., K. W. Tinsley, P. E. Swanson, K. C. Chang, J. P. Cobb, T. G. Buchman, S. J. Korsmeyer, and I. E. Karl. 1999. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc. Natl. Acad. Sci. USA 96: 14541-14546.
13. Xie, Y. C., X. W. Dong, X. M. Wu, X. F. Yan, and Q. M. Xie. 2009. Inhibitory effects of flavonoids extracted from licorice on lipopolysaccharide- induced acute pulmonary inflammation in mice. Int. Immunopharmacol. 9: 194-200.
14. Harris, J. F., J. Aden, C. R. Lyons, and Y. Tesfaigzi. 2007. Resolution of LPS-induced airway inflammation and goblet cell hyperplasia is independent of IL-18. Respir. Res. 8: 24.
15. Morris, P. E., J. Glass, R. Cross, and D. A. Cohen. 1997. Role of T-lymphocytes in the resolution of endotoxin-induced lung injury. Inflammation 21: 269-278.
16. D'Alessio, F. R., K. Tsushima, N. R. Aggarwal, E. E. West, M. H. Willett, M. F. Britos, M. R. Pipeling, R. G. Brower, R. M. Tuder, J. F. McDyer, and L. S. King. 2009. CD4+CD25+Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J. Clin. Invest. 119: 2898-2913.
17. D'Souza, N. B., F. J. Mandujano, S. Nelson, W. R. Summer, and J. E. Shellito. 1994. CD4+ T lymphocyte depletion attenuates lipopolysaccharide- induced tumor necrosis factor secretion by alveolar macrophages in the mouse. Lymphokine Cytokine Res. 13: 359-366.
18. Crowe, C. R., K. Chen, D. A. Pociask, J. F. Alcorn, C. Krivich, R. I. Enelow, T. M. Ross, J. L. Witztum, and J. K. Kolls. 2009. Critical role of IL-17RA in immunopathology of influenza infection. J. Immunol. 183: 5301-5310.
19. Philippakis, G. E., A. C. Lazaris, T. G. Papathomas, C. Zissis, G. Agrogiannis, G. Thomopoulou, A. Nonni, K. Xiromeritis, P. Nikolopoulou-Stamati, J. Bramis, et al. 2008. Adrenaline attenuates the acute lung injury after intratracheal lipopolysaccharide instillation: an experimental study. Inhal. Toxicol. 20: 445-453.
20. Suratt, B. T., and P. E. Parsons. 2006. Mechanisms of acute lung injury/acute respiratory distress syndrome. Clin. Chest Med. 27: 579-589, abstract viii.
21. Ye, P., P. B. Garvey, P. Zhang, S. Nelson, G. Bagby, W. R. Summer, P. Schwarzenberger, J. E. Shellito, and J. K. Kolls. 2001. Interleukin-17 and lung host defense against Klebsiella pneumoniae infection. Am. J. Respir. Cell Mol. Biol. 25: 335-340.
22. Ye, P., F. H. Rodriguez, S. Kanaly, K. L. Stocking, J. Schurr, P. Schwarzenberger, P. Oliver,W. Huang, P. Zhang, J. Zhang, et al. 2001. Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J. Exp. Med. 194: 519-527.
23. Langrish, C. L., Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201: 233-240.
24. Prause, O., A. Bossios, E. Silverpil, S. Ivanov, S. Bozinovski, R. Vlahos, M. Sjöstrand, G. P. Anderson, and A. Lindén. 2009. IL-17-producing T lymphocytes in lung tissue and in the bronchoalveolar space after exposure to endotoxin from Escherichia coli in vivo - effects of anti-inflammatory pharmacotherapy. Pulm. Pharmacol. Ther. 22: 199-207.
25. Miyamoto, M., O. Prause, M. Sjöstrand, M. Laan, J. Lötvall, and A. Lindén. 2003. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J. Immunol. 170: 4665-4672. (Pubitemid 36519973)
26. Ferretti, S., O. Bonneau, G. R. Dubois, C. E. Jones, and A. Trifilieff. 2003. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J. Immunol. 170: 2106-2112.
27. Schnyder-Candrian, S., D. Togbe, I. Couillin, I. Mercier, F. Brombacher, V. Quesniaux, F. Fossiez, B. Ryffel, and B. Schnyder. 2006. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 203: 2715-2725.
28. Braun, R. K., C. Ferrick, P. Neubauer, M. Sjoding, A. Sterner-Kock, M. Kock, L. Putney, D. A. Ferrick, D. M. Hyde, and R. B. Love. 2008. IL-17 producing gammadelta T cells are required for a controlled inflammatory response after bleomycin-induced lung injury. Inflammation 31: 167-179.
29. Otani, K., T. Watanabe, T. Tanigawa, H. Okazaki, H. Yamagami, K. Watanabe, K. Tominaga, Y. Fujiwara, N. Oshitani, and T. Arakawa. 2009. Anti-inflammatory effects of IL-17A on Helicobacter pylori-induced gastritis. Biochem. Biophys. Res. Commun. 382: 252-258.
30. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
31. Krummel, M. F., and J. P. Allison. 1996. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183: 2533-2540.
32. Mattern, T., H. D. Flad, L. Brade, E. T. Rietschel, and A. J. Ulmer. 1998. Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. J. Immunol. 160: 3412-3418. (Pubitemid 28164734)
33. Zheng, Y., and A. Y. Rudensky. 2007. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8: 457-462.
34. Kavanagh, B., S. O'Brien, D. Lee, Y. Hou, V. Weinberg, B. Rini, J. P. Allison, E. J. Small, and L. Fong. 2008. CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion. Blood 112: 1175-1183.
35. Tang, A. L., J. R. Teijaro, M. N. Njau, S. S. Chandran, A. Azimzadeh, S. G. Nadler, D. M. Rothstein, and D. L. Farber. 2008. CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasis. J. Immunol. 181: 1806-1813.